Molecular-Diagnostics-in-Cancer-Testing-Sales-Market-Report-2017
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
Global <strong>Molecular</strong> <strong>Diagnostics</strong> <strong>in</strong> <strong>Cancer</strong> Test<strong>in</strong>g<br />
<strong>Sales</strong> <strong>Market</strong> <strong>Report</strong> <strong>2017</strong><br />
No of Pages – 120<br />
Publish<strong>in</strong>g Date - February 3, <strong>2017</strong><br />
Browse detailed TOC, Tables, Figures, Charts <strong>in</strong> Global <strong>Molecular</strong> <strong>Diagnostics</strong> <strong>in</strong> <strong>Cancer</strong><br />
Test<strong>in</strong>g <strong>Sales</strong> <strong>Market</strong> <strong>Report</strong> <strong>2017</strong> at- http://www.marketreportsworld.com/10306061<br />
Notes:<br />
<strong>Sales</strong>, means the sales volume of <strong>Molecular</strong> <strong>Diagnostics</strong> <strong>in</strong> <strong>Cancer</strong> Test<strong>in</strong>g<br />
Revenue, means the sales value of <strong>Molecular</strong> <strong>Diagnostics</strong> <strong>in</strong> <strong>Cancer</strong> Test<strong>in</strong>g<br />
This report studies sales (consumption) of <strong>Molecular</strong> <strong>Diagnostics</strong> <strong>in</strong> <strong>Cancer</strong> Test<strong>in</strong>g <strong>in</strong> Global<br />
market, especially <strong>in</strong> United States, Ch<strong>in</strong>a, Europe and Japan, focuses on top players <strong>in</strong> these<br />
regions/countries, with sales, price, revenue and market share for each player <strong>in</strong> these regions,<br />
cover<strong>in</strong>g<br />
Abbott <strong>Molecular</strong> <strong>Diagnostics</strong><br />
Accugenomics<br />
Agendia<br />
Ambry Genetics<br />
Biodesix<br />
bioMerieux<br />
bioTheranostics (AviaraDx)<br />
<strong>Cancer</strong> Genetics<br />
Clarient, Inc. (GE Healthcare)<br />
Counsyl<br />
Flatiron Health<br />
Epigenomics<br />
Exact Sciences Corporation<br />
Exiqon<br />
Genomic Health<br />
Genoptix (Novartis)<br />
Genmark <strong>Diagnostics</strong><br />
Genomictree<br />
HTG <strong>Molecular</strong> <strong>Diagnostics</strong><br />
Invitae<br />
LabCorp<br />
Myriad Genetics<br />
Nanostr<strong>in</strong>g<br />
Neogenomics<br />
NSTG<br />
Nuvera Biosciences<br />
Orion Genomics<br />
Pathway Genomics
<strong>Market</strong> Segment by Regions, this report splits Global <strong>in</strong>to several key Regions, with sales<br />
(consumption), revenue, market share and growth rate of <strong>Molecular</strong> <strong>Diagnostics</strong> <strong>in</strong> <strong>Cancer</strong> Test<strong>in</strong>g <strong>in</strong><br />
these regions, from 2011 to 2021 (forecast), like<br />
United States<br />
Ch<strong>in</strong>a<br />
Europe<br />
Japan<br />
Southeast Asia<br />
India<br />
Split by product Types, with sales, revenue, price and gross marg<strong>in</strong>, market share and growth rate of<br />
each type, can be divided <strong>in</strong>to<br />
Type I<br />
Type II<br />
Split by applications, this report focuses on sales, market share and growth rate of <strong>Molecular</strong><br />
<strong>Diagnostics</strong> <strong>in</strong> <strong>Cancer</strong> Test<strong>in</strong>g <strong>in</strong> each application, can be divided <strong>in</strong>to<br />
Application 1<br />
Application 2<br />
Ask for Discount at – http://www.marketreportsworld.com/enquiry/request-discount/10306061<br />
Table of Contents<br />
Global <strong>Molecular</strong> <strong>Diagnostics</strong> <strong>in</strong> <strong>Cancer</strong> Test<strong>in</strong>g <strong>Sales</strong> <strong>Market</strong> <strong>Report</strong> <strong>2017</strong><br />
1 <strong>Molecular</strong> <strong>Diagnostics</strong> <strong>in</strong> <strong>Cancer</strong> Test<strong>in</strong>g Overview<br />
1.1 Product Overview and Scope of <strong>Molecular</strong> <strong>Diagnostics</strong> <strong>in</strong> <strong>Cancer</strong> Test<strong>in</strong>g<br />
1.2 Classification of <strong>Molecular</strong> <strong>Diagnostics</strong> <strong>in</strong> <strong>Cancer</strong> Test<strong>in</strong>g<br />
1.2.1 Type I<br />
1.2.2 Type II<br />
1.3 Application of <strong>Molecular</strong> <strong>Diagnostics</strong> <strong>in</strong> <strong>Cancer</strong> Test<strong>in</strong>g<br />
1.3.1 Application 1<br />
1.3.2 Application 2<br />
1.4 <strong>Molecular</strong> <strong>Diagnostics</strong> <strong>in</strong> <strong>Cancer</strong> Test<strong>in</strong>g <strong>Market</strong> by Regions<br />
1.4.1 United States Status and Prospect (2012-2022)<br />
1.4.2 Ch<strong>in</strong>a Status and Prospect (2012-2022)<br />
1.4.3 Europe Status and Prospect (2012-2022)<br />
1.4.4 Japan Status and Prospect (2012-2022)<br />
1.4.5 Southeast Asia Status and Prospect (2012-2022)<br />
1.4.6 India Status and Prospect (2012-2022)<br />
1.5 Global <strong>Market</strong> Size (Value and Volume) of <strong>Molecular</strong> <strong>Diagnostics</strong> <strong>in</strong> <strong>Cancer</strong> Test<strong>in</strong>g<br />
(2012-2022)<br />
1.5.1 Global <strong>Molecular</strong> <strong>Diagnostics</strong> <strong>in</strong> <strong>Cancer</strong> Test<strong>in</strong>g <strong>Sales</strong> and Growth Rate (2012-2022)<br />
1.5.2 Global <strong>Molecular</strong> <strong>Diagnostics</strong> <strong>in</strong> <strong>Cancer</strong> Test<strong>in</strong>g Revenue and Growth Rate (2012-2022)<br />
2 Global <strong>Molecular</strong> <strong>Diagnostics</strong> <strong>in</strong> <strong>Cancer</strong> Test<strong>in</strong>g Competition by Manufacturers, Type and<br />
Application<br />
2.1 Global <strong>Molecular</strong> <strong>Diagnostics</strong> <strong>in</strong> <strong>Cancer</strong> Test<strong>in</strong>g <strong>Market</strong> Competition by Manufacturers<br />
2.1.1 Global <strong>Molecular</strong> <strong>Diagnostics</strong> <strong>in</strong> <strong>Cancer</strong> Test<strong>in</strong>g <strong>Sales</strong> and <strong>Market</strong> Share of Key Manufacturers<br />
(2012-<strong>2017</strong>)
2.1.2 Global <strong>Molecular</strong> <strong>Diagnostics</strong> <strong>in</strong> <strong>Cancer</strong> Test<strong>in</strong>g Revenue and Share by Manufacturers<br />
(2012-<strong>2017</strong>)<br />
2.2 Global <strong>Molecular</strong> <strong>Diagnostics</strong> <strong>in</strong> <strong>Cancer</strong> Test<strong>in</strong>g (Volume and Value) by Type<br />
2.2.1 Global <strong>Molecular</strong> <strong>Diagnostics</strong> <strong>in</strong> <strong>Cancer</strong> Test<strong>in</strong>g <strong>Sales</strong> and <strong>Market</strong> Share by Type (2012-<strong>2017</strong>)<br />
2.2.2 Global <strong>Molecular</strong> <strong>Diagnostics</strong> <strong>in</strong> <strong>Cancer</strong> Test<strong>in</strong>g Revenue and <strong>Market</strong> Share by Type<br />
(2012-<strong>2017</strong>)<br />
2.3 Global <strong>Molecular</strong> <strong>Diagnostics</strong> <strong>in</strong> <strong>Cancer</strong> Test<strong>in</strong>g (Volume and Value) by Regions<br />
2.3.1 Global <strong>Molecular</strong> <strong>Diagnostics</strong> <strong>in</strong> <strong>Cancer</strong> Test<strong>in</strong>g <strong>Sales</strong> and <strong>Market</strong> Share by Regions<br />
(2012-<strong>2017</strong>)<br />
2.3.2 Global <strong>Molecular</strong> <strong>Diagnostics</strong> <strong>in</strong> <strong>Cancer</strong> Test<strong>in</strong>g Revenue and <strong>Market</strong> Share by Regions<br />
(2012-<strong>2017</strong>)<br />
2.4 Global <strong>Molecular</strong> <strong>Diagnostics</strong> <strong>in</strong> <strong>Cancer</strong> Test<strong>in</strong>g (Volume) by Application<br />
3 United States <strong>Molecular</strong> <strong>Diagnostics</strong> <strong>in</strong> <strong>Cancer</strong> Test<strong>in</strong>g (Volume, Value and <strong>Sales</strong> Price)<br />
3.1 United States <strong>Molecular</strong> <strong>Diagnostics</strong> <strong>in</strong> <strong>Cancer</strong> Test<strong>in</strong>g <strong>Sales</strong> and Value (2012-<strong>2017</strong>)<br />
3.1.1 United States <strong>Molecular</strong> <strong>Diagnostics</strong> <strong>in</strong> <strong>Cancer</strong> Test<strong>in</strong>g <strong>Sales</strong> and Growth Rate (2012-<strong>2017</strong>)<br />
3.1.2 United States <strong>Molecular</strong> <strong>Diagnostics</strong> <strong>in</strong> <strong>Cancer</strong> Test<strong>in</strong>g Revenue and Growth Rate (2012-<strong>2017</strong>)<br />
3.1.3 United States <strong>Molecular</strong> <strong>Diagnostics</strong> <strong>in</strong> <strong>Cancer</strong> Test<strong>in</strong>g <strong>Sales</strong> Price Trend (2012-<strong>2017</strong>)<br />
3.2 United States <strong>Molecular</strong> <strong>Diagnostics</strong> <strong>in</strong> <strong>Cancer</strong> Test<strong>in</strong>g <strong>Sales</strong> and <strong>Market</strong> Share by Manufacturers<br />
3.3 United States <strong>Molecular</strong> <strong>Diagnostics</strong> <strong>in</strong> <strong>Cancer</strong> Test<strong>in</strong>g <strong>Sales</strong> and <strong>Market</strong> Share by Type<br />
3.4 United States <strong>Molecular</strong> <strong>Diagnostics</strong> <strong>in</strong> <strong>Cancer</strong> Test<strong>in</strong>g <strong>Sales</strong> and <strong>Market</strong> Share by Application<br />
4 Ch<strong>in</strong>a <strong>Molecular</strong> <strong>Diagnostics</strong> <strong>in</strong> <strong>Cancer</strong> Test<strong>in</strong>g (Volume, Value and <strong>Sales</strong> Price)<br />
4.1 Ch<strong>in</strong>a <strong>Molecular</strong> <strong>Diagnostics</strong> <strong>in</strong> <strong>Cancer</strong> Test<strong>in</strong>g <strong>Sales</strong> and Value (2012-<strong>2017</strong>)<br />
4.1.1 Ch<strong>in</strong>a <strong>Molecular</strong> <strong>Diagnostics</strong> <strong>in</strong> <strong>Cancer</strong> Test<strong>in</strong>g <strong>Sales</strong> and Growth Rate (2012-<strong>2017</strong>)<br />
4.1.2 Ch<strong>in</strong>a <strong>Molecular</strong> <strong>Diagnostics</strong> <strong>in</strong> <strong>Cancer</strong> Test<strong>in</strong>g Revenue and Growth Rate (2012-<strong>2017</strong>)<br />
4.1.3 Ch<strong>in</strong>a <strong>Molecular</strong> <strong>Diagnostics</strong> <strong>in</strong> <strong>Cancer</strong> Test<strong>in</strong>g <strong>Sales</strong> Price Trend (2012-<strong>2017</strong>)<br />
4.2 Ch<strong>in</strong>a <strong>Molecular</strong> <strong>Diagnostics</strong> <strong>in</strong> <strong>Cancer</strong> Test<strong>in</strong>g <strong>Sales</strong> and <strong>Market</strong> Share by Manufacturers<br />
4.3 Ch<strong>in</strong>a <strong>Molecular</strong> <strong>Diagnostics</strong> <strong>in</strong> <strong>Cancer</strong> Test<strong>in</strong>g <strong>Sales</strong> and <strong>Market</strong> Share by Type<br />
4.4 Ch<strong>in</strong>a <strong>Molecular</strong> <strong>Diagnostics</strong> <strong>in</strong> <strong>Cancer</strong> Test<strong>in</strong>g <strong>Sales</strong> and <strong>Market</strong> Share by Application<br />
5 Europe <strong>Molecular</strong> <strong>Diagnostics</strong> <strong>in</strong> <strong>Cancer</strong> Test<strong>in</strong>g (Volume, Value and <strong>Sales</strong> Price)<br />
5.1 Europe <strong>Molecular</strong> <strong>Diagnostics</strong> <strong>in</strong> <strong>Cancer</strong> Test<strong>in</strong>g <strong>Sales</strong> and Value (2012-<strong>2017</strong>)<br />
5.1.1 Europe <strong>Molecular</strong> <strong>Diagnostics</strong> <strong>in</strong> <strong>Cancer</strong> Test<strong>in</strong>g <strong>Sales</strong> and Growth Rate (2012-<strong>2017</strong>)<br />
5.1.2 Europe <strong>Molecular</strong> <strong>Diagnostics</strong> <strong>in</strong> <strong>Cancer</strong> Test<strong>in</strong>g Revenue and Growth Rate (2012-<strong>2017</strong>)<br />
5.1.3 Europe <strong>Molecular</strong> <strong>Diagnostics</strong> <strong>in</strong> <strong>Cancer</strong> Test<strong>in</strong>g <strong>Sales</strong> Price Trend (2012-<strong>2017</strong>)<br />
5.2 Europe <strong>Molecular</strong> <strong>Diagnostics</strong> <strong>in</strong> <strong>Cancer</strong> Test<strong>in</strong>g <strong>Sales</strong> and <strong>Market</strong> Share by Manufacturers<br />
5.3 Europe <strong>Molecular</strong> <strong>Diagnostics</strong> <strong>in</strong> <strong>Cancer</strong> Test<strong>in</strong>g <strong>Sales</strong> and <strong>Market</strong> Share by Type<br />
5.4 Europe <strong>Molecular</strong> <strong>Diagnostics</strong> <strong>in</strong> <strong>Cancer</strong> Test<strong>in</strong>g <strong>Sales</strong> and <strong>Market</strong> Share by Application<br />
6 Japan <strong>Molecular</strong> <strong>Diagnostics</strong> <strong>in</strong> <strong>Cancer</strong> Test<strong>in</strong>g (Volume, Value and <strong>Sales</strong> Price)<br />
6.1 Japan <strong>Molecular</strong> <strong>Diagnostics</strong> <strong>in</strong> <strong>Cancer</strong> Test<strong>in</strong>g <strong>Sales</strong> and Value (2012-<strong>2017</strong>)<br />
6.1.1 Japan <strong>Molecular</strong> <strong>Diagnostics</strong> <strong>in</strong> <strong>Cancer</strong> Test<strong>in</strong>g <strong>Sales</strong> and Growth Rate (2012-<strong>2017</strong>)<br />
6.1.2 Japan <strong>Molecular</strong> <strong>Diagnostics</strong> <strong>in</strong> <strong>Cancer</strong> Test<strong>in</strong>g Revenue and Growth Rate (2012-<strong>2017</strong>)<br />
6.1.3 Japan <strong>Molecular</strong> <strong>Diagnostics</strong> <strong>in</strong> <strong>Cancer</strong> Test<strong>in</strong>g <strong>Sales</strong> Price Trend (2012-<strong>2017</strong>)<br />
6.2 Japan <strong>Molecular</strong> <strong>Diagnostics</strong> <strong>in</strong> <strong>Cancer</strong> Test<strong>in</strong>g <strong>Sales</strong> and <strong>Market</strong> Share by Manufacturers<br />
6.3 Japan <strong>Molecular</strong> <strong>Diagnostics</strong> <strong>in</strong> <strong>Cancer</strong> Test<strong>in</strong>g <strong>Sales</strong> and <strong>Market</strong> Share by Type<br />
6.4 Japan <strong>Molecular</strong> <strong>Diagnostics</strong> <strong>in</strong> <strong>Cancer</strong> Test<strong>in</strong>g <strong>Sales</strong> and <strong>Market</strong> Share by Application<br />
7 Southeast Asia <strong>Molecular</strong> <strong>Diagnostics</strong> <strong>in</strong> <strong>Cancer</strong> Test<strong>in</strong>g (Volume, Value and <strong>Sales</strong> Price)<br />
7.1 Southeast Asia <strong>Molecular</strong> <strong>Diagnostics</strong> <strong>in</strong> <strong>Cancer</strong> Test<strong>in</strong>g <strong>Sales</strong> and Value (2012-<strong>2017</strong>)
7.1.1 Southeast Asia <strong>Molecular</strong> <strong>Diagnostics</strong> <strong>in</strong> <strong>Cancer</strong> Test<strong>in</strong>g <strong>Sales</strong> and Growth Rate (2012-<strong>2017</strong>)<br />
7.1.2 Southeast Asia <strong>Molecular</strong> <strong>Diagnostics</strong> <strong>in</strong> <strong>Cancer</strong> Test<strong>in</strong>g Revenue and Growth Rate<br />
(2012-<strong>2017</strong>)<br />
7.1.3 Southeast Asia <strong>Molecular</strong> <strong>Diagnostics</strong> <strong>in</strong> <strong>Cancer</strong> Test<strong>in</strong>g <strong>Sales</strong> Price Trend (2012-<strong>2017</strong>)<br />
7.2 Southeast Asia <strong>Molecular</strong> <strong>Diagnostics</strong> <strong>in</strong> <strong>Cancer</strong> Test<strong>in</strong>g <strong>Sales</strong> and <strong>Market</strong> Share by<br />
Manufacturers<br />
7.3 Southeast Asia <strong>Molecular</strong> <strong>Diagnostics</strong> <strong>in</strong> <strong>Cancer</strong> Test<strong>in</strong>g <strong>Sales</strong> and <strong>Market</strong> Share by Type<br />
7.4 Southeast Asia <strong>Molecular</strong> <strong>Diagnostics</strong> <strong>in</strong> <strong>Cancer</strong> Test<strong>in</strong>g <strong>Sales</strong> and <strong>Market</strong> Share by Application<br />
8 India <strong>Molecular</strong> <strong>Diagnostics</strong> <strong>in</strong> <strong>Cancer</strong> Test<strong>in</strong>g (Volume, Value and <strong>Sales</strong> Price)<br />
8.1 India <strong>Molecular</strong> <strong>Diagnostics</strong> <strong>in</strong> <strong>Cancer</strong> Test<strong>in</strong>g <strong>Sales</strong> and Value (2012-<strong>2017</strong>)<br />
8.1.1 India <strong>Molecular</strong> <strong>Diagnostics</strong> <strong>in</strong> <strong>Cancer</strong> Test<strong>in</strong>g <strong>Sales</strong> and Growth Rate (2012-<strong>2017</strong>)<br />
8.1.2 India <strong>Molecular</strong> <strong>Diagnostics</strong> <strong>in</strong> <strong>Cancer</strong> Test<strong>in</strong>g Revenue and Growth Rate (2012-<strong>2017</strong>)<br />
8.1.3 India <strong>Molecular</strong> <strong>Diagnostics</strong> <strong>in</strong> <strong>Cancer</strong> Test<strong>in</strong>g <strong>Sales</strong> Price Trend (2012-<strong>2017</strong>)<br />
8.2 India <strong>Molecular</strong> <strong>Diagnostics</strong> <strong>in</strong> <strong>Cancer</strong> Test<strong>in</strong>g <strong>Sales</strong> and <strong>Market</strong> Share by Manufacturers<br />
8.3 India <strong>Molecular</strong> <strong>Diagnostics</strong> <strong>in</strong> <strong>Cancer</strong> Test<strong>in</strong>g <strong>Sales</strong> and <strong>Market</strong> Share by Type<br />
8.4 India <strong>Molecular</strong> <strong>Diagnostics</strong> <strong>in</strong> <strong>Cancer</strong> Test<strong>in</strong>g <strong>Sales</strong> and <strong>Market</strong> Share by Application<br />
9 Global <strong>Molecular</strong> <strong>Diagnostics</strong> <strong>in</strong> <strong>Cancer</strong> Test<strong>in</strong>g Manufacturers Analysis<br />
9.1 Abbott <strong>Molecular</strong> <strong>Diagnostics</strong><br />
9.1.1 Company Basic Information, Manufactur<strong>in</strong>g Base and Competitors<br />
9.1.2 <strong>Molecular</strong> <strong>Diagnostics</strong> <strong>in</strong> <strong>Cancer</strong> Test<strong>in</strong>g Product Type, Application and Specification<br />
9.1.2.1 Product A<br />
9.1.2.2 Product B<br />
9.1.3 Abbott <strong>Molecular</strong> <strong>Diagnostics</strong> <strong>Molecular</strong> <strong>Diagnostics</strong> <strong>in</strong> <strong>Cancer</strong> Test<strong>in</strong>g <strong>Sales</strong>, Revenue, Price<br />
and Gross Marg<strong>in</strong> (2012-<strong>2017</strong>)<br />
9.1.4 Ma<strong>in</strong> Bus<strong>in</strong>ess/Bus<strong>in</strong>ess Overview<br />
9.2 Accugenomics<br />
9.2.1 Company Basic Information, Manufactur<strong>in</strong>g Base and Competitors<br />
9.2.2 <strong>Molecular</strong> <strong>Diagnostics</strong> <strong>in</strong> <strong>Cancer</strong> Test<strong>in</strong>g Product Type, Application and Specification<br />
9.2.2.1 Product A<br />
9.2.2.2 Product B<br />
9.2.3 Accugenomics <strong>Molecular</strong> <strong>Diagnostics</strong> <strong>in</strong> <strong>Cancer</strong> Test<strong>in</strong>g <strong>Sales</strong>, Revenue, Price and Gross<br />
Marg<strong>in</strong> (2012-<strong>2017</strong>)<br />
9.2.4 Ma<strong>in</strong> Bus<strong>in</strong>ess/Bus<strong>in</strong>ess Overview<br />
9.3 Agendia<br />
9.3.1 Company Basic Information, Manufactur<strong>in</strong>g Base and Competitors<br />
9.3.2 <strong>Molecular</strong> <strong>Diagnostics</strong> <strong>in</strong> <strong>Cancer</strong> Test<strong>in</strong>g Product Type, Application and Specification<br />
9.3.2.1 Product A<br />
9.3.2.2 Product B<br />
9.3.3 Agendia <strong>Molecular</strong> <strong>Diagnostics</strong> <strong>in</strong> <strong>Cancer</strong> Test<strong>in</strong>g <strong>Sales</strong>, Revenue, Price and Gross Marg<strong>in</strong><br />
(2012-<strong>2017</strong>)<br />
9.3.4 Ma<strong>in</strong> Bus<strong>in</strong>ess/Bus<strong>in</strong>ess Overview<br />
9.4 Ambry Genetics<br />
9.4.1 Company Basic Information, Manufactur<strong>in</strong>g Base and Competitors<br />
9.4.2 <strong>Molecular</strong> <strong>Diagnostics</strong> <strong>in</strong> <strong>Cancer</strong> Test<strong>in</strong>g Product Type, Application and Specification<br />
9.4.2.1 Product A<br />
9.4.2.2 Product B<br />
9.4.3 Ambry Genetics <strong>Molecular</strong> <strong>Diagnostics</strong> <strong>in</strong> <strong>Cancer</strong> Test<strong>in</strong>g <strong>Sales</strong>, Revenue, Price and Gross<br />
Marg<strong>in</strong> (2012-<strong>2017</strong>)<br />
9.4.4 Ma<strong>in</strong> Bus<strong>in</strong>ess/Bus<strong>in</strong>ess Overview
9.5 Biodesix<br />
9.5.1 Company Basic Information, Manufactur<strong>in</strong>g Base and Competitors<br />
9.5.2 <strong>Molecular</strong> <strong>Diagnostics</strong> <strong>in</strong> <strong>Cancer</strong> Test<strong>in</strong>g Product Type, Application and Specification<br />
9.5.2.1 Product A<br />
9.5.2.2 Product B<br />
9.5.3 Biodesix <strong>Molecular</strong> <strong>Diagnostics</strong> <strong>in</strong> <strong>Cancer</strong> Test<strong>in</strong>g <strong>Sales</strong>, Revenue, Price and Gross Marg<strong>in</strong><br />
(2012-<strong>2017</strong>)<br />
9.5.4 Ma<strong>in</strong> Bus<strong>in</strong>ess/Bus<strong>in</strong>ess Overview<br />
9.6 bioMerieux<br />
9.6.1 Company Basic Information, Manufactur<strong>in</strong>g Base and Competitors<br />
9.6.2 <strong>Molecular</strong> <strong>Diagnostics</strong> <strong>in</strong> <strong>Cancer</strong> Test<strong>in</strong>g Product Type, Application and Specification<br />
9.6.2.1 Product A<br />
9.6.2.2 Product B<br />
9.6.3 bioMerieux <strong>Molecular</strong> <strong>Diagnostics</strong> <strong>in</strong> <strong>Cancer</strong> Test<strong>in</strong>g <strong>Sales</strong>, Revenue, Price and Gross Marg<strong>in</strong><br />
(2012-<strong>2017</strong>)<br />
9.6.4 Ma<strong>in</strong> Bus<strong>in</strong>ess/Bus<strong>in</strong>ess Overview<br />
9.7 bioTheranostics (AviaraDx)<br />
9.7.1 Company Basic Information, Manufactur<strong>in</strong>g Base and Competitors<br />
9.7.2 <strong>Molecular</strong> <strong>Diagnostics</strong> <strong>in</strong> <strong>Cancer</strong> Test<strong>in</strong>g Product Type, Application and Specification<br />
9.7.2.1 Product A<br />
9.7.2.2 Product B<br />
9.7.3 bioTheranostics (AviaraDx) <strong>Molecular</strong> <strong>Diagnostics</strong> <strong>in</strong> <strong>Cancer</strong> Test<strong>in</strong>g <strong>Sales</strong>, Revenue, Price<br />
and Gross Marg<strong>in</strong> (2012-<strong>2017</strong>)<br />
9.7.4 Ma<strong>in</strong> Bus<strong>in</strong>ess/Bus<strong>in</strong>ess Overview<br />
9.8 <strong>Cancer</strong> Genetics<br />
9.8.1 Company Basic Information, Manufactur<strong>in</strong>g Base and Competitors<br />
9.8.2 <strong>Molecular</strong> <strong>Diagnostics</strong> <strong>in</strong> <strong>Cancer</strong> Test<strong>in</strong>g Product Type, Application and Specification<br />
9.8.2.1 Product A<br />
9.8.2.2 Product B<br />
9.8.3 <strong>Cancer</strong> Genetics <strong>Molecular</strong> <strong>Diagnostics</strong> <strong>in</strong> <strong>Cancer</strong> Test<strong>in</strong>g <strong>Sales</strong>, Revenue, Price and Gross<br />
Marg<strong>in</strong> (2012-<strong>2017</strong>)<br />
9.8.4 Ma<strong>in</strong> Bus<strong>in</strong>ess/Bus<strong>in</strong>ess Overview<br />
9.9 Clarient, Inc. (GE Healthcare)<br />
9.9.1 Company Basic Information, Manufactur<strong>in</strong>g Base and Competitors<br />
9.9.2 <strong>Molecular</strong> <strong>Diagnostics</strong> <strong>in</strong> <strong>Cancer</strong> Test<strong>in</strong>g Product Type, Application and Specification<br />
9.9.2.1 Product A<br />
9.9.2.2 Product B<br />
9.9.3 Clarient, Inc. (GE Healthcare) <strong>Molecular</strong> <strong>Diagnostics</strong> <strong>in</strong> <strong>Cancer</strong> Test<strong>in</strong>g <strong>Sales</strong>, Revenue, Price<br />
and Gross Marg<strong>in</strong> (2012-<strong>2017</strong>)<br />
9.9.4 Ma<strong>in</strong> Bus<strong>in</strong>ess/Bus<strong>in</strong>ess Overview<br />
9.10 Counsyl<br />
9.10.1 Company Basic Information, Manufactur<strong>in</strong>g Base and Competitors<br />
9.10.2 <strong>Molecular</strong> <strong>Diagnostics</strong> <strong>in</strong> <strong>Cancer</strong> Test<strong>in</strong>g Product Type, Application and Specification<br />
9.10.2.1 Product A<br />
9.10.2.2 Product B<br />
9.10.3 Counsyl <strong>Molecular</strong> <strong>Diagnostics</strong> <strong>in</strong> <strong>Cancer</strong> Test<strong>in</strong>g <strong>Sales</strong>, Revenue, Price and Gross Marg<strong>in</strong><br />
(2012-<strong>2017</strong>)<br />
9.10.4 Ma<strong>in</strong> Bus<strong>in</strong>ess/Bus<strong>in</strong>ess Overview<br />
9.11 Flatiron Health<br />
9.12 Epigenomics
9.13 Exact Sciences Corporation<br />
9.14 Exiqon<br />
9.15 Genomic Health<br />
9.16 Genoptix (Novartis)<br />
9.17 Genmark <strong>Diagnostics</strong><br />
9.18 Genomictree<br />
9.19 HTG <strong>Molecular</strong> <strong>Diagnostics</strong><br />
9.20 Invitae<br />
9.21 LabCorp<br />
9.22 Myriad Genetics<br />
9.23 Nanostr<strong>in</strong>g<br />
9.24 Neogenomics<br />
9.25 NSTG<br />
9.26 Nuvera Biosciences<br />
9.27 Orion Genomics<br />
9.28 Pathway Genomics<br />
10 <strong>Molecular</strong> <strong>Diagnostics</strong> <strong>in</strong> <strong>Cancer</strong> Test<strong>in</strong>g Maufactur<strong>in</strong>g Cost Analysis<br />
10.1 <strong>Molecular</strong> <strong>Diagnostics</strong> <strong>in</strong> <strong>Cancer</strong> Test<strong>in</strong>g Key Raw Materials Analysis<br />
10.1.1 Key Raw Materials<br />
10.1.2 Price Trend of Key Raw Materials<br />
10.1.3 Key Suppliers of Raw Materials<br />
10.1.4 <strong>Market</strong> Concentration Rate of Raw Materials<br />
10.2 Proportion of Manufactur<strong>in</strong>g Cost Structure<br />
10.2.1 Raw Materials<br />
10.2.2 Labor Cost<br />
10.2.3 Manufactur<strong>in</strong>g Process Analysis of <strong>Molecular</strong> <strong>Diagnostics</strong> <strong>in</strong> <strong>Cancer</strong> Test<strong>in</strong>g<br />
10.3 Manufactur<strong>in</strong>g Process Analysis of <strong>Molecular</strong> <strong>Diagnostics</strong> <strong>in</strong> <strong>Cancer</strong> Test<strong>in</strong>g<br />
11 Industrial Cha<strong>in</strong>, Sourc<strong>in</strong>g Strategy and Downstream Buyers<br />
11.1 <strong>Molecular</strong> <strong>Diagnostics</strong> <strong>in</strong> <strong>Cancer</strong> Test<strong>in</strong>g Industrial Cha<strong>in</strong> Analysis<br />
11.2 Upstream Raw Materials Sourc<strong>in</strong>g<br />
11.3 Raw Materials Sources of <strong>Molecular</strong> <strong>Diagnostics</strong> <strong>in</strong> <strong>Cancer</strong> Test<strong>in</strong>g Major Manufacturers <strong>in</strong><br />
2015<br />
11.4 Downstream Buyers<br />
12 <strong>Market</strong><strong>in</strong>g Strategy Analysis, Distributors/Traders<br />
12.1 <strong>Market</strong><strong>in</strong>g Channel<br />
12.1.1 Direct <strong>Market</strong><strong>in</strong>g<br />
12.1.2 Indirect <strong>Market</strong><strong>in</strong>g<br />
12.1.3 <strong>Market</strong><strong>in</strong>g Channel Development Trend<br />
12.2 <strong>Market</strong> Position<strong>in</strong>g<br />
12.2.1 Pric<strong>in</strong>g Strategy<br />
12.2.2 Brand Strategy<br />
12.2.3 Target Client<br />
12.3 Distributors/Traders List<br />
13 <strong>Market</strong> Effect Factors Analysis<br />
13.1 Technology Progress/Risk<br />
13.1.1 Substitutes Threat
13.1.2 Technology Progress <strong>in</strong> Related Industry<br />
13.2 Consumer Needs/Customer Preference Change<br />
13.3 Economic/Political Environmental Change<br />
14 Global <strong>Molecular</strong> <strong>Diagnostics</strong> <strong>in</strong> <strong>Cancer</strong> Test<strong>in</strong>g <strong>Market</strong> Forecast (<strong>2017</strong>-2022)<br />
14.1 Global <strong>Molecular</strong> <strong>Diagnostics</strong> <strong>in</strong> <strong>Cancer</strong> Test<strong>in</strong>g <strong>Sales</strong>, Revenue and Price Forecast (<strong>2017</strong>-2022)<br />
14.1.1 Global <strong>Molecular</strong> <strong>Diagnostics</strong> <strong>in</strong> <strong>Cancer</strong> Test<strong>in</strong>g <strong>Sales</strong> and Growth Rate Forecast (<strong>2017</strong>-2022)<br />
14.1.2 Global <strong>Molecular</strong> <strong>Diagnostics</strong> <strong>in</strong> <strong>Cancer</strong> Test<strong>in</strong>g Revenue and Growth Rate Forecast<br />
(<strong>2017</strong>-2022)<br />
14.1.3 Global <strong>Molecular</strong> <strong>Diagnostics</strong> <strong>in</strong> <strong>Cancer</strong> Test<strong>in</strong>g Price and Trend Forecast (<strong>2017</strong>-2022)<br />
14.2 Global <strong>Molecular</strong> <strong>Diagnostics</strong> <strong>in</strong> <strong>Cancer</strong> Test<strong>in</strong>g <strong>Sales</strong>, Revenue and Growth Rate Forecast by<br />
Regions (<strong>2017</strong>-2022)<br />
14.2.1 United States <strong>Molecular</strong> <strong>Diagnostics</strong> <strong>in</strong> <strong>Cancer</strong> Test<strong>in</strong>g <strong>Sales</strong>, Revenue and Growth Rate<br />
Forecast (<strong>2017</strong>-2022)<br />
14.2.2 Ch<strong>in</strong>a <strong>Molecular</strong> <strong>Diagnostics</strong> <strong>in</strong> <strong>Cancer</strong> Test<strong>in</strong>g <strong>Sales</strong>, Revenue and Growth Rate Forecast<br />
(<strong>2017</strong>-2022)<br />
14.2.3 Europe <strong>Molecular</strong> <strong>Diagnostics</strong> <strong>in</strong> <strong>Cancer</strong> Test<strong>in</strong>g <strong>Sales</strong>, Revenue and Growth Rate Forecast<br />
(<strong>2017</strong>-2022)<br />
14.2.4 Japan <strong>Molecular</strong> <strong>Diagnostics</strong> <strong>in</strong> <strong>Cancer</strong> Test<strong>in</strong>g <strong>Sales</strong>, Revenue and Growth Rate Forecast<br />
(<strong>2017</strong>-2022)<br />
14.2.5 Southeast Asia <strong>Molecular</strong> <strong>Diagnostics</strong> <strong>in</strong> <strong>Cancer</strong> Test<strong>in</strong>g <strong>Sales</strong>, Revenue and Growth Rate<br />
Forecast (<strong>2017</strong>-2022)<br />
14.2.6 India <strong>Molecular</strong> <strong>Diagnostics</strong> <strong>in</strong> <strong>Cancer</strong> Test<strong>in</strong>g <strong>Sales</strong>, Revenue and Growth Rate Forecast<br />
(<strong>2017</strong>-2022)<br />
14.3 Global <strong>Molecular</strong> <strong>Diagnostics</strong> <strong>in</strong> <strong>Cancer</strong> Test<strong>in</strong>g <strong>Sales</strong>, Revenue and Price Forecast by Type<br />
(<strong>2017</strong>-2022)<br />
14.4 Global <strong>Molecular</strong> <strong>Diagnostics</strong> <strong>in</strong> <strong>Cancer</strong> Test<strong>in</strong>g <strong>Sales</strong> Forecast by Application (<strong>2017</strong>-2022)<br />
15 Research F<strong>in</strong>d<strong>in</strong>gs and Conclusion<br />
16 Appendix<br />
Methodology<br />
Analyst Introduction<br />
Data Source<br />
<strong>Report</strong> Details –<br />
Date of Publish<strong>in</strong>g - February 3, <strong>2017</strong><br />
No of Pages – 120<br />
S<strong>in</strong>gle User PDF License – $4000<br />
Corporate License – $8000<br />
Buy Now - http://www.marketreportsworld.com/purchase/10306061<br />
About <strong>Market</strong> <strong>Report</strong>s World: <strong>Market</strong> <strong>Report</strong>s World is the credible source for ga<strong>in</strong><strong>in</strong>g the market<br />
research reports that will exponentially accelerate your bus<strong>in</strong>ess. We are among the lead<strong>in</strong>g report<br />
resellers <strong>in</strong> the bus<strong>in</strong>ess world committed towards optimiz<strong>in</strong>g your bus<strong>in</strong>ess. The reports we provide<br />
are based on a research that covers a magnitude of factors such as technological evolution, economic
Powered by TCPDF (www.tcpdf.org)<br />
Powered by TCPDF (www.tcpdf.org)<br />
shifts and a detailed study of market segments.<br />
Contact–<br />
Mr. Ameya P<strong>in</strong>galey<br />
<strong>Market</strong> <strong>Report</strong>s World<br />
+1-408 520 9750<br />
Email – sales@marketreportsworld.com<br />
www.marketreportsworld.com
Change language